This study is looking at how Jatenzo Pill, an oral testosterone medicine, affects men who have low testosterone (hypogonadism) and chronic kidney disease. Researchers want to see if Jatenzo Pill can increase testosterone levels, improve red blood cells (hemoglobin), muscle strength, and sexual function. You might be able to join if you are a man between 18 and 85 years old, have chronic kidney disease (eGFR 15-45 ml/min/1.73m2), and have low testosterone levels (below 300 ng/dl on two separate occasions) along with symptoms like low sex drive or fatigue. The main goal is to measure your testosterone levels after 6 months of treatment. The study is currently unclear on its recruitment status and plans to enroll 20 participants.

Study design

This is an interventional study with 20 planned participants. It will evaluate the effects of Jatenzo Pill.

What's involved

You would take Jatenzo Pill daily for 6 months. You would have research visits every 2-4 weeks, which include blood draws, physical exams, vital signs, questionnaires, body scans, and muscle strength tests.

Compensation

Not stated in the trial record.

Follow-up

Testosterone concentrations are measured at 6 months, which is the duration of the drug treatment.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.